Graft and patient survival rates were 93% and 100%, respectively.
移植物存活率和患者存活率分别为93%和100%。
Graft and patient survival rates among patients with ANCA-associated vasculitis are comparable to those observed in nondiabetic patients.
移植物和患者的生存率与ANCA相关性血管炎的患者相比，那些在非糖尿病患者中观察到。
The primary end point was dialysis independence at 3 mo. Secondary end points included renal and patient survival at 1 yr and severe adverse event rates.
初级终点为3个月时脱离透析。次级终点包括一年时肾脏和患者生存率以及严重的不良事件。
Patient survival and severe adverse event rates were similar in both groups.
两组患者生存率和严重不良事件发生率相似。
Patient survival and severe adverse event rates were similar in both groups.
两组患者生存率和严重不良事件发生率相似。
应用推荐